Last reviewed · How we verify
gefitinib and fulvestrant
gefitinib and fulvestrant is a Small molecule drug developed by AstraZeneca. It is currently in Phase 2 development.
At a glance
| Generic name | gefitinib and fulvestrant |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer (PHASE2)
- Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR (PHASE2)
- Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer (PHASE2)
- Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer (PHASE2)
- A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gefitinib and fulvestrant CI brief — competitive landscape report
- gefitinib and fulvestrant updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about gefitinib and fulvestrant
What is gefitinib and fulvestrant?
gefitinib and fulvestrant is a Small molecule drug developed by AstraZeneca.
Who makes gefitinib and fulvestrant?
gefitinib and fulvestrant is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is gefitinib and fulvestrant in?
gefitinib and fulvestrant is in Phase 2.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: gefitinib and fulvestrant vs similar drugs
- Pricing: gefitinib and fulvestrant cost, discount & access